Attend the FierceBiotech Drug Development Forum
The leading executive-level forum for biotech strategy & networking | Oct 28-29 | Boston
A Stanford team has proposed a strategy for coaxing supporting cells in the brain to transform into memory-preserving neurons.
The week’s biotech news included a form of CRISPR that can edit 25 genes at once and a drug that helps blood cells recover from cancer treatment.
A Scripps Research team identified the GPR139 receptor as a regulator that could reduce opioids' toxic withdrawal effects.
AstraZeneca’s AZD1775 extended median survival in pancreatic cancer when combined with chemo and radiation in a phase 1 trial.
A phase 1 clinical trial of Ziopharm's IL-12 gene therapy and a production "switch" shows promise in recurrent glioblastoma.
A research team discovered that some pancreatic tumors overproduce perlecan, a type of protein that helps cancer cells spread.
Using single-cell RNA sequencing, scientists have uncovered new cellular changes that could drive the progression of NASH.
Scientists created HIV-specific T cells that have two CAR molecules instead of one, and they've charted promising results in mice.
Stanford researchers discovered that immune cells known for their ability to root out cancer can also kill wayward cells that cause MS.
A combination of cardiac muscle cells and epicardial cells derived from stem cells restored damaged heart tissue in a rat study.